1. Home
  2. MKSI vs RGEN Comparison

MKSI vs RGEN Comparison

Compare MKSI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKSI
  • RGEN
  • Stock Information
  • Founded
  • MKSI 1961
  • RGEN 1981
  • Country
  • MKSI United States
  • RGEN United States
  • Employees
  • MKSI N/A
  • RGEN N/A
  • Industry
  • MKSI Industrial Machinery/Components
  • RGEN Medical/Dental Instruments
  • Sector
  • MKSI Industrials
  • RGEN Health Care
  • Exchange
  • MKSI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • MKSI 5.0B
  • RGEN 8.0B
  • IPO Year
  • MKSI 1999
  • RGEN N/A
  • Fundamental
  • Price
  • MKSI $104.66
  • RGEN $127.47
  • Analyst Decision
  • MKSI Buy
  • RGEN Buy
  • Analyst Count
  • MKSI 11
  • RGEN 12
  • Target Price
  • MKSI $131.73
  • RGEN $170.40
  • AVG Volume (30 Days)
  • MKSI 943.2K
  • RGEN 694.0K
  • Earning Date
  • MKSI 08-06-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • MKSI 0.84%
  • RGEN N/A
  • EPS Growth
  • MKSI N/A
  • RGEN N/A
  • EPS
  • MKSI 3.36
  • RGEN N/A
  • Revenue
  • MKSI $3,654,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • MKSI $7.00
  • RGEN $13.93
  • Revenue Next Year
  • MKSI $6.70
  • RGEN $14.35
  • P/E Ratio
  • MKSI $31.14
  • RGEN N/A
  • Revenue Growth
  • MKSI N/A
  • RGEN 4.88
  • 52 Week Low
  • MKSI $54.84
  • RGEN $102.97
  • 52 Week High
  • MKSI $147.40
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • MKSI 71.72
  • RGEN 54.11
  • Support Level
  • MKSI $97.16
  • RGEN $121.44
  • Resistance Level
  • MKSI $100.80
  • RGEN $131.43
  • Average True Range (ATR)
  • MKSI 3.03
  • RGEN 4.47
  • MACD
  • MKSI 0.73
  • RGEN 0.61
  • Stochastic Oscillator
  • MKSI 94.46
  • RGEN 74.57

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: